Become A Featured Company

Supreme Cannabis Focused on Disciplined Deployment of Capital

Ryan Allway

November 21st, 2018

Exclusive, News, Top News

The cannabis industry has boomed in recent years supported by the access to inexpensive capital, which has stemmed from a voracious investor appetite for cannabis exposure and the prospects of outsized returns. In turn, many licensed producers have quickly deployed any raised capital to feed the investor frenzy and the demand for growth prospects and transactions without necessarily looking at the long-run and the need to maximize return on capital.

There are a few exceptions to this, and the Supreme Cannabis Co. (TSX-V: FIRE) (OTCQX: SPRWF) is an issuer that has taken a disciplined approach with a focus on maximizing shareholder value over the long-run by ensuring prudent capital management and allocation.

Utilizing Product Experts in a Segmenting Market

A recent clear example of Supreme’s strategy can be found in its approach to cannabis extract production. Cannabis oils have had a significant share of the medical cannabis market, according to Health Canada. As such, it is not surprising that many licensed producers have invested significant capital in building out large extraction facilities to produce cannabis oils. Dedicating capital to this function is a calculated risk with a rapidly evolving market and international opportunities on the horizon that might require this capital.        

Supreme Cannabis has generally taken a contrarian view in its approach to the market. In the case of domestic cannabis oil extraction, Supreme Cannabis has not deployed capital to build domestic oil facilities. Instead, the company has operated on the thesis that as the cannabis market evolved it would naturally segment, and dedicated product experts would be established. This is the same trend the company has observed in mature US markets.  

Supreme’s thesis played out correctly as dedicated extraction companies such as MediPharm Labs Corp. (TSX-V: LABS) and Neptune Wellness Solutions Inc. (TSX: NEPT) (NASDAQ: NEPT) have come to market. The company recently signed a deal with MediPharm to produce Supreme’s first line of cannabis oils. Supreme will provide an initial 1,000 kilograms of dried cannabis flower that will be converted into approximately 200,000 40ml tinctures in the first year. The agreement runs for three years, and the initial amounts constitute minimum annual production levels which can be increased as needed. Canopy Growth (TSX: WEED) (NYSE: CGC) also has taken advantage of these experts – supplementing its extraction capabilities with an agreement with Neptune.

This agreement provides Supreme with the same cannabis oil market exposure as its peers with none of the capital costs and associated risks – allowing the company to deploy capital in other opportunities.   

Supreme Cannabis Becomes Sixth Largest Canadian LP by Revenues

Supreme Cannabis Co.’s revenue rose 229 percent to $5.14 million during its first quarter of fiscal 2019 (calendar Q3). These results are driven by a growing number of supply agreements with other licensed producers and deals with six provinces to supply recreational cannabis to consumers.

At an annual revenue run rate of $20.6M, these results rank Supreme sixth among the Canadian LPs: 1) Aurora Cannabis (TSX:ACB) (NYSE:ACB) has a revenue run rate of $118M, 2) Canopy Growth at $93M, 3) Aphria (TSX:APHA) (NYSE:APHA) at $53M, 4) Tilray Inc. (NASDAQ:TLRY) at $52M, and 5) CannTrust (TSX:TRST) at $50.35M. It is noteworthy that every single one of the LPs listed above trades a significant valuation premium to Supreme Cannabis, as well as several companies with lower reported revenues.  

Looking Ahead

The Supreme Cannabis Co. (TSX-V: FIRE) (OTCQX: SPRWF) represents a compelling investment opportunity in the burgeoning cannabis industry. With its disciplined approach to the market, the company is laser-focused on generating high rates of return on its deployed capital and ultimately building significant long-term shareholder value.

For more information, visit the company’s website or download its investor presentation.

Disclaimer

The above article is sponsored content. Emerging Growth LLC, which owns CannabisFN.com and CFN Media, has been hired to create awareness. Please follow the link below to view our full disclosure outlining our compensation: https://cannabisfn.com/legal-disclaimer/

This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.

About Ryan Allway

Mr. Allway has over a decade of experience in the financial markets as both a private investor and financial journalist. He has been actively involved in the cannabis industry since its inception, covering public and private companies.

Network Partners

Follow Us on Social Media

LinkedIn

About CFN Media Group

CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.

Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.

Copyright © Accelerize Inc. · All Rights Reserved · Privacy Policy · Legal Disclaimer

loading